tiprankstipranks
Gemini Therapeutics (GMTX)
NASDAQ:GMTX
US Market

Gemini Therapeutics (GMTX) Stock Forecast & Price Target

116 Followers
See the Price Targets and Ratings of:

GMTX Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Gemini
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

GMTX Stock 12 Month Forecast

There Are No Analyst Ratings for GMTX In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

GMTX Financial Forecast

GMTX Earnings Forecast

Next quarter’s earnings estimate for GMTX is -$5.90 with a range of -$5.90 to -$5.90. The previous quarter’s EPS was -$0.08. GMTX beat its EPS estimate 66.67% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.65% of the time in the same period. In the last calendar year GMTX has Outperformed its overall industry.
Next quarter’s earnings estimate for GMTX is -$5.90 with a range of -$5.90 to -$5.90. The previous quarter’s EPS was -$0.08. GMTX beat its EPS estimate 66.67% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.65% of the time in the same period. In the last calendar year GMTX has Outperformed its overall industry.
No data currently available

GMTX Sales Forecast

The previous quarter’s earnings for GMTX were $0.00.
The previous quarter’s earnings for GMTX were $0.00.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
SVB Securities
$2.00
Hold
48.15%
Upside
Reiterated
07/11/22
Gemini Therapeutics (GMTX) Gets a Hold Rating from SVB Securities
Jefferies
$1.50
Hold
11.11%
Upside
Downgraded
03/01/22
Read Why Did Jefferies Downgrade Gemini Therapeutics To HoldHe has reduced the odds of success of GEM103 to 0% in his model to arrive at his new price target, Howerton noted.
Stifel Nicolaus
$2.00
Hold
48.15%
Upside
Downgraded
02/28/22
Stifel downgrades Gemini Therapeutics (GMTX) to Hold, Slashes Price Target to $2, Cites Lower Probability of Success for GEM103 and Higher Overall RisksStifel analyst Paul Matteis downgraded Gemini Therapeutics Inc. (NASDAQ: GMTX) from Buy to Hold with a price target of $2.00 (from $11.00), following the companys most recent corporate update.

GMTX Analyst Recommendation Trends

Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

GMTX Stock Forecast FAQ

What is GMTX’s average 12-month price target, according to analysts?
Currently, no data Available
What is GMTX’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for GMTX, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is GMTX a Buy, Sell or Hold?
      Currently, no data Available
      What is Gemini Therapeutics’s price target?
      Currently, no data Available
      What do analysts say about Gemini Therapeutics?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of GMTX?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis